This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2014
Title: Alenka Paris: Innovator in Pharmaceutical Composition
Introduction
Alenka Paris is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of erythropoietin (EPO). With a total of 2 patents, her work has the potential to impact the medical industry positively.
Latest Patents
Alenka's latest patents include a stable pharmaceutical composition comprising erythropoietin. The first patent presents a new stable pharmaceutical composition of EPO that is stabilized with PVP. The second patent also focuses on a stable pharmaceutical composition of EPO, but it is stabilized with a combination of a poloxamer polyol and a polyhydric alcohol. These innovations are crucial for enhancing the efficacy and stability of EPO in medical applications.
Career Highlights
Alenka Paris is currently associated with Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. Her work at Lek Pharmaceuticals has allowed her to explore innovative solutions in drug formulation and stabilization.
Collaborations
Alenka collaborates with talented professionals such as Andreja Vukmirovic and Tanja Rozman Peterka. Their teamwork fosters a creative environment that drives innovation in pharmaceutical research.
Conclusion
Alenka Paris is a remarkable inventor whose contributions to pharmaceutical compositions are noteworthy. Her patents reflect her dedication to improving medical treatments and advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile